This webinar examines the clinical and pathologic response to neoadjuvant chemotherapy for locally advanced breast cancer at Kijabe Hospital in Kenya, where breast cancer mortality remains high and treatment data are limited. By strengthening access to in-house immunohistochemistry testing and evaluating residual cancer burden, the study aims to improve treatment decision-making, pathology reporting, and policy guidance for breast cancer care in Kenya.

Presenters:

Rondi Kauffmann, MD, MPH
Vanderbilt  University Medical Center and Kijabe Hospital in Kijabe, Kenya

Rosemary Wangari Kamau, MMed, Pathology
Kijabe Mission Hospital in Embu County, Kijabe, Kenya and The Pathology Network (TPN)